Statistics for Compass Therapeutics (id:5364 CMPX)

Valuation metrics

Market cap

189.87M

Enterprise value

61.35M

Trailing P/E (ttm)

-4.52

Forward P/E

-2.71

PEG ratio

-2.71

Price/Sales (ttm)

223.38

Price/Book (mrq)

1.37

Enterprise Value/Revenue

72.17

Enterprise Value/EBITDA

-1.12

Overview

Shares outstanding

137.59M

Float

88.57M

Shares short

1.79M

% Held by insiders

0.12%

% Held by institutions

0.69%

Average volume (10 days)

642.34K

Average volume (90 days)

Price summary

52-Week low

0.76

52-Week high

2.34

52-Week change

-15.44%

Beta

0.75

50-Day moving average

1.75

200-Day moving average

1.52

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-6,522.82%

Operational effectiveness

Return on assets

-21.71%

Return on equity

-32.00%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-54,834,000.00

Net income to common (ttm)

-47,757,000.00

Diluted EPS (ttm)

-0.35

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

135.40M

Total cash per share (mrq)

0.98

Total debt (mrq)

6.88M

Total Debt/Equity (mrq)

4.97

Current ratio (mrq)

3.18K%

Book value per share (mrq)

1.01

Cash flow

Cash flow statement

-48,047,000.00

Levered free cash flow (LFCF)

-31,852,500.00